Oral Anti-diabetes Drugs Market - Global Outlook and Forecast 2023-2027

Report ID: 614076 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Oral Anti-diabetes Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Oral Anti-diabetes Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Oral Anti-diabetes Drugs Overall Market Size
    2.1 Global Oral Anti-diabetes Drugs Market Size: 2021 VS 2027
    2.2 Global Oral Anti-diabetes Drugs Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Oral Anti-diabetes Drugs Players in Global Market
    3.2 Top Global Oral Anti-diabetes Drugs Companies Ranked by Revenue
    3.3 Global Oral Anti-diabetes Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Oral Anti-diabetes Drugs Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Oral Anti-diabetes Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Oral Anti-diabetes Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Oral Anti-diabetes Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Oral Anti-diabetes Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Oral Anti-diabetes Drugs Market Size Markets, 2021 & 2027
        4.1.2 Liquid
        4.1.3 Capsule
        4.1.4 Tablet
    4.2 By Type - Global Oral Anti-diabetes Drugs Revenue & Forecasts
        4.2.1 By Type - Global Oral Anti-diabetes Drugs Revenue, 2016-2021
        4.2.2 By Type - Global Oral Anti-diabetes Drugs Revenue, 2022-2027
        4.2.3 By Type - Global Oral Anti-diabetes Drugs Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Oral Anti-diabetes Drugs Market Size, 2021 & 2027
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Oral Anti-diabetes Drugs Revenue & Forecasts
        5.2.1 By Application - Global Oral Anti-diabetes Drugs Revenue, 2016-2021
        5.2.2 By Application - Global Oral Anti-diabetes Drugs Revenue, 2022-2027
        5.2.3 By Application - Global Oral Anti-diabetes Drugs Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Oral Anti-diabetes Drugs Market Size, 2021 & 2027
    6.2 By Region - Global Oral Anti-diabetes Drugs Revenue & Forecasts
        6.2.1 By Region - Global Oral Anti-diabetes Drugs Revenue, 2016-2021
        6.2.2 By Region - Global Oral Anti-diabetes Drugs Revenue, 2022-2027
        6.2.3 By Region - Global Oral Anti-diabetes Drugs Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Oral Anti-diabetes Drugs Revenue, 2016-2027
        6.3.2 US Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.3.3 Canada Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.3.4 Mexico Oral Anti-diabetes Drugs Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Oral Anti-diabetes Drugs Revenue, 2016-2027
        6.4.2 Germany Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.4.3 France Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.4.4 U.K. Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.4.5 Italy Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.4.6 Russia Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.4.7 Nordic Countries Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.4.8 Benelux Oral Anti-diabetes Drugs Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Oral Anti-diabetes Drugs Revenue, 2016-2027
        6.5.2 China Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.5.3 Japan Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.5.4 South Korea Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.5.5 Southeast Asia Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.5.6 India Oral Anti-diabetes Drugs Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Oral Anti-diabetes Drugs Revenue, 2016-2027
        6.6.2 Brazil Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.6.3 Argentina Oral Anti-diabetes Drugs Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Oral Anti-diabetes Drugs Revenue, 2016-2027
        6.7.2 Turkey Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.7.3 Israel Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.7.4 Saudi Arabia Oral Anti-diabetes Drugs Market Size, 2016-2027
        6.7.5 UAE Oral Anti-diabetes Drugs Market Size, 2016-2027
7 Players Profiles
    7.1 Sanofi
        7.1.1 Sanofi Corporate Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Oral Anti-diabetes Drugs Major Product Offerings
        7.1.4 Sanofi Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.1.5 Sanofi Key News
    7.2 Eli Lilly
        7.2.1 Eli Lilly Corporate Summary
        7.2.2 Eli Lilly Business Overview
        7.2.3 Eli Lilly Oral Anti-diabetes Drugs Major Product Offerings
        7.2.4 Eli Lilly Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.2.5 Eli Lilly Key News
    7.3 AstraZeneca plc
        7.3.1 AstraZeneca plc Corporate Summary
        7.3.2 AstraZeneca plc Business Overview
        7.3.3 AstraZeneca plc Oral Anti-diabetes Drugs Major Product Offerings
        7.3.4 AstraZeneca plc Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.3.5 AstraZeneca plc Key News
    7.4 Astellas Pharma Inc
        7.4.1 Astellas Pharma Inc Corporate Summary
        7.4.2 Astellas Pharma Inc Business Overview
        7.4.3 Astellas Pharma Inc Oral Anti-diabetes Drugs Major Product Offerings
        7.4.4 Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.4.5 Astellas Pharma Inc Key News
    7.5 Johnson & Johnson (Janssen Pharmaceuticals)
        7.5.1 Johnson & Johnson (Janssen Pharmaceuticals) Corporate Summary
        7.5.2 Johnson & Johnson (Janssen Pharmaceuticals) Business Overview
        7.5.3 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Major Product Offerings
        7.5.4 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.5.5 Johnson & Johnson (Janssen Pharmaceuticals) Key News
    7.6 Boehringer Ingelheim
        7.6.1 Boehringer Ingelheim Corporate Summary
        7.6.2 Boehringer Ingelheim Business Overview
        7.6.3 Boehringer Ingelheim Oral Anti-diabetes Drugs Major Product Offerings
        7.6.4 Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.6.5 Boehringer Ingelheim Key News
    7.7 Merck
        7.7.1 Merck Corporate Summary
        7.7.2 Merck Business Overview
        7.7.3 Merck Oral Anti-diabetes Drugs Major Product Offerings
        7.4.4 Merck Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.7.5 Merck Key News
    7.8 Takeda
        7.8.1 Takeda Corporate Summary
        7.8.2 Takeda Business Overview
        7.8.3 Takeda Oral Anti-diabetes Drugs Major Product Offerings
        7.8.4 Takeda Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.8.5 Takeda Key News
    7.9 Bristol Myers Squibb
        7.9.1 Bristol Myers Squibb Corporate Summary
        7.9.2 Bristol Myers Squibb Business Overview
        7.9.3 Bristol Myers Squibb Oral Anti-diabetes Drugs Major Product Offerings
        7.9.4 Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.9.5 Bristol Myers Squibb Key News
    7.10 Novartis
        7.10.1 Novartis Corporate Summary
        7.10.2 Novartis Business Overview
        7.10.3 Novartis Oral Anti-diabetes Drugs Major Product Offerings
        7.10.4 Novartis Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.10.5 Novartis Key News
    7.11 Pfizer
        7.11.1 Pfizer Corporate Summary
        7.11.2 Pfizer Business Overview
        7.11.3 Pfizer Oral Anti-diabetes Drugs Major Product Offerings
        7.11.4 Pfizer Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.11.5 Pfizer Key News
    7.12 Abbott
        7.12.1 Abbott Corporate Summary
        7.12.2 Abbott Business Overview
        7.12.3 Abbott Oral Anti-diabetes Drugs Major Product Offerings
        7.12.4 Abbott Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.12.5 Abbott Key News
    7.13 Biocon
        7.13.1 Biocon Corporate Summary
        7.13.2 Biocon Business Overview
        7.13.3 Biocon Oral Anti-diabetes Drugs Major Product Offerings
        7.13.4 Biocon Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.13.5 Biocon Key News
    7.14 Sunpharma
        7.14.1 Sunpharma Corporate Summary
        7.14.2 Sunpharma Business Overview
        7.14.3 Sunpharma Oral Anti-diabetes Drugs Major Product Offerings
        7.14.4 Sunpharma Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.14.5 Sunpharma Key News
    7.15 Novo Nordisk
        7.15.1 Novo Nordisk Corporate Summary
        7.15.2 Novo Nordisk Business Overview
        7.15.3 Novo Nordisk Oral Anti-diabetes Drugs Major Product Offerings
        7.15.4 Novo Nordisk Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.15.5 Novo Nordisk Key News
    7.16 Piramal Healthcare
        7.16.1 Piramal Healthcare Corporate Summary
        7.16.2 Piramal Healthcare Business Overview
        7.16.3 Piramal Healthcare Oral Anti-diabetes Drugs Major Product Offerings
        7.16.4 Piramal Healthcare Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.16.5 Piramal Healthcare Key News
    7.17 Bayer Healthcare
        7.17.1 Bayer Healthcare Corporate Summary
        7.17.2 Bayer Healthcare Business Overview
        7.17.3 Bayer Healthcare Oral Anti-diabetes Drugs Major Product Offerings
        7.17.4 Bayer Healthcare Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.17.5 Bayer Healthcare Key News
    7.18 Dr. Reddy’s Laboratories Ltd
        7.18.1 Dr. Reddy’s Laboratories Ltd Corporate Summary
        7.18.2 Dr. Reddy’s Laboratories Ltd Business Overview
        7.18.3 Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Major Product Offerings
        7.18.4 Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.18.5 Dr. Reddy’s Laboratories Ltd Key News
    7.19 Glenmark Pharmaceuticals Ltd
        7.19.1 Glenmark Pharmaceuticals Ltd Corporate Summary
        7.19.2 Glenmark Pharmaceuticals Ltd Business Overview
        7.19.3 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Major Product Offerings
        7.19.4 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue in Global (2016-2021)
        7.19.5 Glenmark Pharmaceuticals Ltd Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Oral Anti-diabetes Drugs Market Opportunities & Trends in Global Market
    Table 2. Oral Anti-diabetes Drugs Market Drivers in Global Market
    Table 3. Oral Anti-diabetes Drugs Market Restraints in Global Market
    Table 4. Key Players of Oral Anti-diabetes Drugs in Global Market
    Table 5. Top Oral Anti-diabetes Drugs Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global Oral Anti-diabetes Drugs Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global Oral Anti-diabetes Drugs Revenue Share by Companies, 2016-2021
    Table 8. Global Companies Oral Anti-diabetes Drugs Product Type
    Table 9. List of Global Tier 1 Oral Anti-diabetes Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Oral Anti-diabetes Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Oral Anti-diabetes Drugs Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - Oral Anti-diabetes Drugs Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - Oral Anti-diabetes Drugs Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - Oral Anti-diabetes Drugs Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global Oral Anti-diabetes Drugs Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global Oral Anti-diabetes Drugs Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2022-2027
    Table 30. Sanofi Corporate Summary
    Table 31. Sanofi Oral Anti-diabetes Drugs Product Offerings
    Table 32. Sanofi Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 33. Eli Lilly Corporate Summary
    Table 34. Eli Lilly Oral Anti-diabetes Drugs Product Offerings
    Table 35. Eli Lilly Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 36. AstraZeneca plc Corporate Summary
    Table 37. AstraZeneca plc Oral Anti-diabetes Drugs Product Offerings
    Table 38. AstraZeneca plc Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 39. Astellas Pharma Inc Corporate Summary
    Table 40. Astellas Pharma Inc Oral Anti-diabetes Drugs Product Offerings
    Table 41. Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 42. Johnson & Johnson (Janssen Pharmaceuticals) Corporate Summary
    Table 43. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product Offerings
    Table 44. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 45. Boehringer Ingelheim Corporate Summary
    Table 46. Boehringer Ingelheim Oral Anti-diabetes Drugs Product Offerings
    Table 47. Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 48. Merck Corporate Summary
    Table 49. Merck Oral Anti-diabetes Drugs Product Offerings
    Table 50. Merck Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 51. Takeda Corporate Summary
    Table 52. Takeda Oral Anti-diabetes Drugs Product Offerings
    Table 53. Takeda Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 54. Bristol Myers Squibb Corporate Summary
    Table 55. Bristol Myers Squibb Oral Anti-diabetes Drugs Product Offerings
    Table 56. Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 57. Novartis Corporate Summary
    Table 58. Novartis Oral Anti-diabetes Drugs Product Offerings
    Table 59. Novartis Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 60. Pfizer Corporate Summary
    Table 61. Pfizer Oral Anti-diabetes Drugs Product Offerings
    Table 62. Pfizer Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 63. Abbott Corporate Summary
    Table 64. Abbott Oral Anti-diabetes Drugs Product Offerings
    Table 65. Abbott Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 66. Biocon Corporate Summary
    Table 67. Biocon Oral Anti-diabetes Drugs Product Offerings
    Table 68. Biocon Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 69. Sunpharma Corporate Summary
    Table 70. Sunpharma Oral Anti-diabetes Drugs Product Offerings
    Table 71. Sunpharma Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 72. Novo Nordisk Corporate Summary
    Table 73. Novo Nordisk Oral Anti-diabetes Drugs Product Offerings
    Table 74. Novo Nordisk Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 75. Piramal Healthcare Corporate Summary
    Table 76. Piramal Healthcare Oral Anti-diabetes Drugs Product Offerings
    Table 77. Piramal Healthcare Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 78. Bayer Healthcare Corporate Summary
    Table 79. Bayer Healthcare Oral Anti-diabetes Drugs Product Offerings
    Table 80. Bayer Healthcare Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 81. Dr. Reddy’s Laboratories Ltd Corporate Summary
    Table 82. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Product Offerings
    Table 83. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
    Table 84. Glenmark Pharmaceuticals Ltd Corporate Summary
    Table 85. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product Offerings
    Table 86. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. Oral Anti-diabetes Drugs Segment by Type
    Figure 2. Oral Anti-diabetes Drugs Segment by Application
    Figure 3. Global Oral Anti-diabetes Drugs Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Oral Anti-diabetes Drugs Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Oral Anti-diabetes Drugs Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Oral Anti-diabetes Drugs Revenue in 2020
    Figure 8. By Type - Global Oral Anti-diabetes Drugs Revenue Market Share, 2016-2027
    Figure 9. By Application - Global Oral Anti-diabetes Drugs Revenue Market Share, 2016-2027
    Figure 10. By Region - Global Oral Anti-diabetes Drugs Revenue Market Share, 2016-2027
    Figure 11. By Country - North America Oral Anti-diabetes Drugs Revenue Market Share, 2016-2027
    Figure 12. US Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe Oral Anti-diabetes Drugs Revenue Market Share, 2016-2027
    Figure 16. Germany Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 17. France Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia Oral Anti-diabetes Drugs Revenue Market Share, 2016-2027
    Figure 24. China Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 28. India Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America Oral Anti-diabetes Drugs Revenue Market Share, 2016-2027
    Figure 30. Brazil Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa Oral Anti-diabetes Drugs Revenue Market Share, 2016-2027
    Figure 33. Turkey Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2016-2027
    Figure 37. Sanofi Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Eli Lilly Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. AstraZeneca plc Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 43. Merck Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 44. Takeda Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 45. Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 46. Novartis Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 47. Pfizer Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 48. Abbott Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 49. Biocon Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 50. Sunpharma Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 51. Novo Nordisk Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 52. Piramal Healthcare Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 53. Bayer Healthcare Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 54. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 55. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Oral Anti-diabetes Drugs Market In Medical Care report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oral Anti-diabetes Drugs Market In Medical Care report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oral Anti-diabetes Drugs Market In Medical Care report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports